Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)

China flag China · Delayed Price · Currency is CNY
30.65
-0.09 (-0.29%)
May 20, 2026, 2:35 PM CST
Market Cap4.72B -32.1%
Revenue (ttm)3.35B -2.2%
Net Income337.40M -9.5%
EPS2.20 -10.5%
Shares Out153.40M
PE Ratio13.98
Forward PEn/a
Dividend0.90 (2.93%)
Ex-Dividend DateApr 28, 2026
Volume683,416
Average Volume1,654,091
Open30.51
Previous Close30.74
Day's Range30.34 - 30.70
52-Week Range30.18 - 43.72
Beta0.20
RSI34.20
Earnings DateMar 21, 2026

About SHA:600976

Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells Chinese medicines in China. It offers pediatric drugs under the Jianmin and Longmu brands. The company also provides OTC, medical, and health products, as well as consultation service. Jianmin Pharmaceutical Group Co.,Ltd. is headquartered in Wuhan, China. [Read more]

Sector Healthcare
Founded 1637
Employees 2,257
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600976
Full Company Profile

Financial Performance

In 2025, SHA:600976's revenue was 3.37 billion, a decrease of -3.85% compared to the previous year's 3.50 billion. Earnings were 359.84 million, a decrease of -0.65%.

Financial Statements